At a glance
ClinicalIndex Comparison RecordN/ACompleted· 370 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Molecular & Clinical Evaluation of Low HDL Syndromes
In Brief
An observational study for Cardiovascular Diseases and 2 related conditions. Completed, enrolled 370 participants.
Detailed Summary
To study the genetic cause of low HDL-C, a risk factor for premature atherosclerotic vascular disease in patients with normal total cholesterol. The focus is primarily on the identification of a single mutation, as has been demonstrated in one family.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Atherosclerosis
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2000
First PostedSep 2000
Primary CompletionJul 2006
TodayJul 2026
First PostedSep 26, 2000
Enrollment StartAug 1, 2000
Primary CompletionJul 1, 2006
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 25.8 years ago